NASDAQ:LIMN | Profit Breakdown | Liminatus Pharma, Inc.

Complete filed revenue-to-profit bridge showing gross profit, operating income, pre-tax income and net income.

Available history
2024-03-31 to 2026-06-30
Data captured

Historical Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2026-06-30-$1.38M-$1.41M
2026-03-31-$1.1M-$1.12M
2025-12-31-$884,211.00-$8.17M
2025-09-30-$701,170.00-$1.82M
2025-06-30-$1.12M$113,287.00
2025-03-31-$264,220.00-$327,526.00
2024-12-31-$167,077.00-$229,752.00
2024-09-30-$543,147.00-$601,372.00
2024-06-30-$909,218.00-$961,207.00
2024-03-31-$247.00-$1.75M

Annual Profit Breakdown

DateRevenueGross profitOperating incomePre-tax incomeNet income
2025-12-31-$2.97M-$10.21M
2024-12-31-$3.33M-$3.55M